Literature DB >> 24611125

Quo vadis? - Monitoring Campylobacter in Germany.

K Stingl1, M-T Knüver1, P Vogt1, C Buhler1, N-J Krüger1, K Alt1, B-A Tenhagen1, M Hartung1, A Schroeter1, L Ellerbroek1, B Appel1, A Käsbohrer1.   

Abstract

Campylobacter is a poorly recognized foodborne pathogen, leading the statistics of bacterially caused human diarrhoea in Europe during the last years. In this review, we present qualitative and quantitative German data obtained in the framework of specific monitoring programs and from routine surveillance. These also comprise recent data on antimicrobial resistances of food isolates. Due to the considerable reduction of in vitro growth capabilities of stressed bacteria, there is a clear discrepancy between the detection limit of Campylobacter by cultivation and its infection potential. Moreover, antimicrobial resistances of Campylobacter isolates established during fattening of livestock are alarming, since they constitute an additional threat to human health. The European Food Safety Authority (EFSA) discusses the establishment of a quantitative limit for Campylobacter contamination of broiler carcasses in order to achieve an appropriate level of protection for consumers. Currently, a considerable amount of German broiler carcasses would not comply with this future criterion. We recommend Campylobacter reduction strategies to be focussed on the prevention of fecal contamination during slaughter. Decontamination is only a sparse option, since the reduction efficiency is low and its success depends on the initial contamination concentration.

Entities:  

Keywords:  Campylobacter traceability; antibiotic resistances; prevalences in animal and food; quantitative detection; reduction strategies

Year:  2012        PMID: 24611125      PMCID: PMC3933994          DOI: 10.1556/EuJMI.2.2012.1.12

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  33 in total

1.  Broiler carcass contamination with Campylobacter from feces during defeathering.

Authors:  M E Berrang; R J Buhr; J A Cason; J A Dickens
Journal:  J Food Prot       Date:  2001-12       Impact factor: 2.077

2.  Culturability, injury and morphological dynamics of thermophilic Campylobacter spp. within a laboratory-based aquatic model system.

Authors:  C Thomas; D Hill; M Mabey
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

3.  Quantification of Campylobacter on the surface and in the muscle of chicken legs at retail.

Authors:  Kathrin Scherer; Edda Bartelt; Christine Sommerfeld; Goetz Hildebrandt
Journal:  J Food Prot       Date:  2006-04       Impact factor: 2.077

4.  Defaecation and weight of the gastrointestinal tract contents after feed and water withdrawal in broilers.

Authors:  P D Warriss; L J Wilkins; S N Brown; A J Phillips; V Allen
Journal:  Br Poult Sci       Date:  2004-02       Impact factor: 2.095

5.  Campylobacter jejuni loss of culturability in aqueous microcosms and ability to resuscitate in a mouse model.

Authors:  Wally Baffone; Annalisa Casaroli; Barbara Citterio; Lucia Pierfelici; Raffaella Campana; Emanuela Vittoria; Emilio Guaglianone; Gianfranco Donelli
Journal:  Int J Food Microbiol       Date:  2005-11-14       Impact factor: 5.277

6.  Investigation of the presence and protective effects of maternal antibodies against Campylobacter jejuni in chickens.

Authors:  S A Cawthraw; D G Newell
Journal:  Avian Dis       Date:  2010-03       Impact factor: 1.577

7.  Physiological characterization of Campylobacter jejuni under cold stresses conditions: its potential for public threat.

Authors:  Warangkhana Chaisowwong; Akiko Kusumoto; Miho Hashimoto; Toshihiko Harada; Khuanwalai Maklon; Keiko Kawamoto
Journal:  J Vet Med Sci       Date:  2011-09-02       Impact factor: 1.267

8.  Evidence for a lineage of virulent bacteriophages that target Campylobacter.

Authors:  Andrew R Timms; Joanna Cambray-Young; Andrew E Scott; Nicola K Petty; Phillippa L Connerton; Louise Clarke; Kathy Seeger; Mike Quail; Nicola Cummings; Duncan J Maskell; Nicholas R Thomson; Ian F Connerton
Journal:  BMC Genomics       Date:  2010-03-30       Impact factor: 3.969

9.  Prevalence of Campylobacter spp. and Yersinia spp. in the pig production.

Authors:  Tanja Wehebrink; Nicole Kemper; Elisabeth grosse Beilage; Joachim Krieter
Journal:  Berl Munch Tierarztl Wochenschr       Date:  2008 Jan-Feb       Impact factor: 0.328

10.  Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity.

Authors:  Stefan Bereswill; André Fischer; Rita Plickert; Lea-Maxie Haag; Bettina Otto; Anja A Kühl; Javid I Dasti; Javid I Dashti; Andreas E Zautner; Melba Muñoz; Christoph Loddenkemper; Uwe Gross; Ulf B Göbel; Markus M Heimesaat
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

View more
  4 in total

1.  Viability Quantitative PCR Utilizing Propidium Monoazide, Spheroplast Formation, and Campylobacter coli as a Bacterial Model.

Authors:  Thomai P Lazou; Eleni G Iossifidou; Athanasios I Gelasakis; Serafeim C Chaintoutis; Chrysostomos I Dovas
Journal:  Appl Environ Microbiol       Date:  2019-10-01       Impact factor: 4.792

Review 2.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  "Limits of control"--crucial parameters for a reliable quantification of viable campylobacter by real-time PCR.

Authors:  Nora-Johanna Krüger; Christiane Buhler; Azuka N Iwobi; Ingrid Huber; Lüppo Ellerbroek; Bernd Appel; Kerstin Stingl
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

4.  Method-Dependent Implications in Foodborne Pathogen Quantification: The Case of Campylobacter coli Survival on Meat as Comparatively Assessed by Colony Count and Viability PCR.

Authors:  Thomai P Lazou; Athanasios I Gelasakis; Serafeim C Chaintoutis; Eleni G Iossifidou; Chrysostomos I Dovas
Journal:  Front Microbiol       Date:  2021-03-01       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.